0001144204-19-008229.txt : 20190214 0001144204-19-008229.hdr.sgml : 20190214 20190214165949 ACCESSION NUMBER: 0001144204-19-008229 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 EFFECTIVENESS DATE: 20190214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ridgeback Capital Investments L.P. CENTRAL INDEX KEY: 0001423994 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12856 FILM NUMBER: 19607903 BUSINESS ADDRESS: STREET 1: 30 STAR ISLAND DRIVE CITY: MIAMI BEACH STATE: FL ZIP: 33139 BUSINESS PHONE: 212-808-7729 MAIL ADDRESS: STREET 1: 30 STAR ISLAND DRIVE CITY: MIAMI BEACH STATE: FL ZIP: 33139 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001423994 XXXXXXXX 12-31-2018 12-31-2018 false Ridgeback Capital Investments L.P.
30 Star Island Drive Miami Beach FL 33139
13F HOLDINGS REPORT 028-12856 Y Ridgeback Capital Investments Ltd. is the general partner of Ridgeback Capital Investments L.P. Pursuant to an investment management agreement, Ridgeback Capital Management LP maintains investment and voting power with respect to the securities held or controlled by Ridgeback Capital Investments Ltd. Wayne Holman, an individual, controls Ridgeback Capital Management LP. Ridgeback Capital Management LP, Ridgeback Capital Investments Ltd. and Wayne Holman do not own any securities reported herein directly.
Ridgeback Capital Investments Ltd., as General Partner, by Bud Holman Director 212-808-7729 /s/ Bud Holman New York NY 02-14-2019 2 1 36967 true 1 0001357610 028-12280 Ridgeback Capital Management LP 2 0001358916 028-12277 Ridgeback Capital Investments Ltd.
INFORMATION TABLE 2 infotable.xml KARYOPHARM THERAPEUTICS INC. COM 48576U106 36967 3945200 SH SOLE 1,2 0 0 3945200